Position
Fidelity in Jade Biosciences, Inc.
Back to the book · All holders of JBIO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $57.9M$14.05 → $22.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.89M | $106.4M | — | — | — | 0.0% |
| Q1 2026 | 7.09M | $99.6M | $14.05 | −$9.51M | $2.68M | 0.0% |
| Q2 2026 | 9.13M | $202.8M | $22.22 | $57.9M | $45.4M | 0.0% |